Navigation Links
World $114 Billion Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - Forecasts to 2022 - Research and Markets
Date:4/6/2017

DUBLIN, Apr. 06, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022" report to their offering.

It is anticipated that the global site specific drug delivery market will cross US$ 114 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications, rising chronic disease incidences, and increasing research related activities for exploring drug delivery therapeutic applications.

The advent of site specific/targeted drug delivery has revolutionized the drug delivery industry. This technique is allowing a previously unattainable level of drug delivery with greater efficiency to target organs and tissues. Due to this ability, the share of site specific drug delivery is incessantly increasing in the drug delivery industry.

The major application areas of targeted drug delivery pulmonary, ocular, oncology, and others including CNS, cardiovascular, etc. Oncology based application is the largest area of application of targeted drug delivery. This large share can be attributed to various research related activities conducted for developing targeted drug delivery approach for cancer.

Moreover, the report also contains the market share of major regions, including North America, Europe, and Asia Pacific. North America holds the largest market share, while Asia Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth are the ongoing researches in China and Australia, which is expanding therapeutic applications of site specific drug delivery to brain disorders. North America and Europe are expected to grow at a modest rate due to less stringent regulatory approval process and advancements in drug delivery technique.

The last segment of the report is entirely devoted to profiling leading companies of the targeted drug delivery industry, including some major players like Celgene Corporation, Arrowhead Pharma, Intezyne, Endocyte, BioDelivery Sciences International, PharmaIN, Mirus Bio, Savara, etc.

Market Dynamics

Market Drivers

  • Increasing Complexity of Drug Molecules
  • Need for Improved Site-Specific Drug Delivery
  • Advent of Nanotechnology in Site-Specific Drug Delivery
  • Increasing Investments

Market Restraints

  • Complexity in Biopharma Supply Chain & Operations
  • Issues in Quality Compliance & Regulatory Screening

Market Opportunities

  • Increasing R&D Spending in Site-Specific Drug Delivery Technologies
  • Surging Demand for In-Licensing Drug Delivery Products & Technologies

Companies Mentioned

  • Arrowhead Pharmaceuticals, Inc.
  • BioDelivery Sciences International, Inc.
  • Celgene Corporation
  • Delpor, Inc.
  • Endocyte, Inc.
  • Intezyne, Inc.
  • Kurve Technology, Inc.
  • Mirus Bio LLC.
  • PharmaIN
  • Savara Inc.

For more information about this report visit http://www.researchandmarkets.com/research/fncr9l/sitespecific

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/world-114-billion-site-specific-drug-delivery-market-by-application-pulmonary-ocular-oncology-cns-cardiovascular---forecasts-to-2022---research-and-markets-300436058.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
2. Wireless Pill Bottle Wins Healthcare Innovation World Cup
3. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
4. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
5. Accuray is Honored for Delivering World-Class Customer Service
6. Worldwide Medical Device Market Reports
7. The New York Times and Vook Publish "A WORLD OF HURT: Fixing Pain Medicines Biggest Mistake"
8. Worldwide Orthopaedic Product Sales Reached $43.1 Billion in 2012, States ORTHOWORLDs Newly-released Orthopaedic Industry Report
9. DebMed to Display Clients Increased Hand Hygiene Compliance Rates and Worlds First Monitored Point-of-Care Dispenser at APIC
10. Infusion Pumps Markets Worldwide - Projected to Reach over $7.6 billion by 2018
11. Biosimilars And Follow-On Biologics: World Market 2013-2023
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... LOS ANGELES , Aug. 17, 2017 ... by CBMJ – Canna Broadcast Media, today reveals its leading ... that Isodiol International Inc., a global cannabis innovator specializing in ... platinum sponsor of the conference. MassRoots, Rambridge™ and The Green ... Signal Bay Inc. and Namaste Vapes™ as silver sponsors. ...
(Date:8/15/2017)... Inc., the creator of the drug Truveta for the treatment ... IPO. The United States spends approximately ... prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... is the fact that Americans spent $42 billion on anxiety medications last ...
(Date:8/10/2017)... 10, 2017  Physical Rehabilitation Network (PRN), acquired the long-standing ... Lakewood, Colorado . The reputable clinic will continue to ... DPT with his staff of four clinicians. Lipkin received his ... brings over 10 years of experience with a strong background ... PT marks the 10th PRN clinic in and around the ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 active patients, ... replacement therapy and integrative medicine, has become a frontrunner for people seeking help ... menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in 2003 by ...
(Date:8/18/2017)... ... August 18, 2017 , ... 800response, the leading provider ... announced today the launch of a redesigned corporate website, 800response.com . ... responsive design, and an enhanced search directory for businesses and advertising agencies to ...
(Date:8/18/2017)... ... ... Our Imaginations: The Infinite God”: shows the importance of God in living a happy ... author, Mark Lawrence, born in Michigan, the author has lived in various communities and ... of God is that I have to be more mindful of feminine qualities to ...
(Date:8/18/2017)... ... ... “Prompted By Love”: a love story thrown into doubt by untimely news. “Prompted ... Nettles has devoted her life to ministry since the age of 12 when she ... however, not fulfilled until 2014 when "The Color of Roses" was published. After ...
(Date:8/17/2017)... ... August 17, 2017 , ... Shared ... and considered extremely effective, very effective, or effective by 85% of respondents, according ... NEJM Catalyst Insights Reports are based on surveys of the NEJM Catalyst Insights ...
Breaking Medicine News(10 mins):